Search research articles
Contact Us
Filters
Showing results (571-580 of 622) with videos related to
Page
of 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2019
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
Filippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, et al.
Cancers
|
November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Karen Aughton, Nils O Elander, Anthony Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis
Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen, et al.
Microbiome
|
May 9, 2023
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer
James L Alexander, Joram M Posma, Alasdair Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study
Juan W Valle, Daniel Palmer, Richard Jackson, et al.
JAMA
|
September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial
John P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.
The Lancet. Oncology
|
March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N Primrose, Richard P Fox, Daniel H Palmer, et al.
Clinical Chemistry
|
August 29, 2018
Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing
Sonia Mansukhani, Louise J Barber, Dimitrios Kleftogiannis, et al.
JCO Precision Oncology
|
October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial
Elisa Fontana, Gift Nyamundanda, David Cunningham, et al.
Leukemia & Lymphoma
|
July 16, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies
Graham P Collins, Tracy N Clevenger, Kathleen A Burke, et al.
Page
of 63
Search research articles
Search
Showing results (571-580 of 622) with videos related to
Sort By:
Page
of 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2019
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
Filippo Pietrantonio, Rosalba Miceli, Alessandra Raimondi, et al.
Cancers
|
November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Karen Aughton, Nils O Elander, Anthony Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis
Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen, et al.
Microbiome
|
May 9, 2023
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer
James L Alexander, Joram M Posma, Alasdair Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study
Juan W Valle, Daniel Palmer, Richard Jackson, et al.
JAMA
|
September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial
John P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.
The Lancet. Oncology
|
March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N Primrose, Richard P Fox, Daniel H Palmer, et al.
Clinical Chemistry
|
August 29, 2018
Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing
Sonia Mansukhani, Louise J Barber, Dimitrios Kleftogiannis, et al.
JCO Precision Oncology
|
October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial
Elisa Fontana, Gift Nyamundanda, David Cunningham, et al.
Leukemia & Lymphoma
|
July 16, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies
Graham P Collins, Tracy N Clevenger, Kathleen A Burke, et al.
Page
of 63